Eagle Pharmaceuticals Probability of Future Pink Sheet Price Finishing Over 32.57
| EGRXDelisted Stock | USD 1.99 0.02 1.02% |
Eagle |
Eagle Pharmaceuticals Target Price Odds to finish over 32.57
The tendency of Eagle Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 32.57 or more in 90 days |
| 1.99 | 90 days | 32.57 | close to zero percent |
Based on a normal probability distribution, the odds of Eagle Pharmaceuticals to move over $ 32.57 or more in 90 days from now is close to zero percent (This Eagle Pharmaceuticals probability density function shows the probability of Eagle Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Eagle Pharmaceuticals price to stay between its current price of $ 1.99 and $ 32.57 at the end of the 90-day period is close to 99 .
Given the investment horizon of 90 days Eagle Pharmaceuticals has a beta of 0.15 suggesting as returns on the market go up, Eagle Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Eagle Pharmaceuticals will be expected to be much smaller as well. Additionally Eagle Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Eagle Pharmaceuticals Price Density |
| Price |
Predictive Modules for Eagle Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eagle Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Eagle Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Eagle Pharmaceuticals is not an exception. The market had few large corrections towards the Eagle Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Eagle Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Eagle Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.22 | |
β | Beta against Dow Jones | 0.15 | |
σ | Overall volatility | 0.88 | |
Ir | Information ratio | -0.2 |
Eagle Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Eagle Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Eagle Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Eagle Pharmaceuticals is not yet fully synchronised with the market data | |
| Eagle Pharmaceuticals generated a negative expected return over the last 90 days | |
| Eagle Pharmaceuticals has high historical volatility and very poor performance | |
| Eagle Pharmaceuticals may become a speculative penny stock | |
| Eagle Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 316.61 M. Net Loss for the year was (2.67 M) with profit before overhead, payroll, taxes, and interest of 221.67 M. | |
| Over 77.0% of the company shares are held by institutions such as insurance companies |
Eagle Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Eagle Pink Sheet often depends not only on the future outlook of the current and potential Eagle Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eagle Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 13.1 M | |
| Cash And Short Term Investments | 55.3 M |
Eagle Pharmaceuticals Technical Analysis
Eagle Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Eagle Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Eagle Pharmaceuticals. In general, you should focus on analyzing Eagle Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Eagle Pharmaceuticals Predictive Forecast Models
Eagle Pharmaceuticals' time-series forecasting models is one of many Eagle Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Eagle Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Eagle Pharmaceuticals
Checking the ongoing alerts about Eagle Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Eagle Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Eagle Pharmaceuticals is not yet fully synchronised with the market data | |
| Eagle Pharmaceuticals generated a negative expected return over the last 90 days | |
| Eagle Pharmaceuticals has high historical volatility and very poor performance | |
| Eagle Pharmaceuticals may become a speculative penny stock | |
| Eagle Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 316.61 M. Net Loss for the year was (2.67 M) with profit before overhead, payroll, taxes, and interest of 221.67 M. | |
| Over 77.0% of the company shares are held by institutions such as insurance companies |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Eagle Pink Sheet
If you are still planning to invest in Eagle Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eagle Pharmaceuticals' history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |